OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
23
Results
Show all
Save search
Copy query
Show results for
Unknown
(23)
Publication Date
Release Date
2021
(5)
2018
(5)
2022
(3)
2023
(2)
2020
(2)
2015
(2)
2025
(1)
2016
(1)
2010
(1)
2008
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Assessment of the genetic and clinical determinants of fracture risk: genome wide association and mendelian randomisation study.
Not available
S-EPMC6113773
|
biostudies-literature
Cite
Effect of Aspirin on Disability-free Survival in the Healthy Elderly.
Not available
S-EPMC6426126
|
biostudies-literature
Cite
Effect of Aspirin on All-Cause Mortality in the Healthy Elderly.
Not available
S-EPMC6433466
|
biostudies-literature
Cite
Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly.
Not available
S-EPMC6289056
|
biostudies-literature
Cite
Lapses in Care Among Patients Assigned to Ranibizumab for Proliferative Diabetic Retinopathy: A Post Hoc Analysis of a Randomized Clinical Trial.
Not available
S-EPMC8532036
|
biostudies-literature
Cite
Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema.
Not available
S-EPMC6568257
|
biostudies-literature
Cite
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.
Not available
S-EPMC4422053
|
biostudies-literature
Cite
Effects of medical therapies on retinopathy progression in type 2 diabetes.
Not available
S-EPMC4026164
|
biostudies-literature
Cite
New genetic loci link adipose and insulin biology to body fat distribution.
Not available
S-EPMC4338562
|
biostudies-literature
Cite
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
Not available
S-EPMC9333998
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets